Unusual and severe symptomatic impairment of neutrophil function after one 
cycle of temozolomide in patients with malignant glioma

Hartmann, P.; Herholz, Karl; Salzberger, B.; Petereit, H. F.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant glioma

MPS-Authors

/persons/resource/persons147189

Herholz, Karl
Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hartmann, P., Herholz, K., Salzberger, B., & Petereit, H. F. (2004). Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant glioma. Annals of Hematology, 83(4), 212-217.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-DA8D-E